[ad_1] Stocks rose solidly on Wall Street in Monday afternoon trading, prompting the S&P 500 to recoup last week’s losses and eclipse its all-time high. The benchmark index rose 1%Read More
Tag: FDA
FDA Approves GHB, a ‘History Rape’ Drug for Rare Sleep Disorder
[ad_1] On the black market, homemade GHB, also known as liquid ecstasy, goop, and G, can be purchased by the clamshell. $5 to $25. But Xyrem and Xywav’s night treatmentsRead More
FDA Targets Vaccine Booster Rate for Patients with Immunodeficiency
[ad_1] The Food and Drug Administration is stepping up efforts to allow extra doses of coronavirus vaccines for Americans with weakened immune systems; This is a change that reflects growingRead More
FDA Aims to Speed Up Extra Doses of Vaccines for Patients with Immunodeficiency
[ad_1] The Food and Drug Administration is stepping up efforts to allow extra doses of coronavirus vaccines for Americans with weakened immune systems; This is a change that reflects growingRead More
FDA Targets Early Approval of Pfizer Vaccine
[ad_1] WASHINGTON — With a new surge of Covid-19 infections plaguing much of the United States, the Food and Drug Administration has stepped up the timeline to fully approve Pfizer-BioNTech’sRead More
FDA Issues Rare Nerve Syndrome Warning to Johnson & Johnson
[ad_1] The database shows only one possible death of a Johnson & Johnson recipient vaccinated from Guillain-Barré syndrome. But the 57-year-old Delaware man has also suffered a heart attack andRead More
FDA to Add Rare Nerve Syndrome Warning to Johnson & Johnson
[ad_1] The Food and Drug Administration plans to warn that Johnson & Johnson’s coronavirus vaccine could lead to an increased risk of a rare neurological condition known as Guillain-Barré syndrome.Read More
FDA Is Investigating Its Own Alzheimer’s Drug Approval
[ad_1] The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease, which hasRead More
In A Reversal, FDA Calls for Limits on Who Takes Alzheimer’s Drugs
[ad_1] Faced with harsh criticism for approving a controversial drug for all Alzheimer’s patients, the Food and Drug Administration has largely narrowed his recommendationsuggests that only those with mild memoryRead More